The Award in Excellence program now in its 15th year, honors former Foundation grant recipients for outstanding career achievements. Every year, PhRMA Foundation grants Awards in Excellence to past awardees who are dramatic, living proof that the Foundation program works and makes a difference. These awards are given to scientists who received a Foundation grant at the outset of their careers in a discipline important to the research-based pharmaceutical industry when they were deciding on their area of specialization and went on to distinguish themselves through their scientific and/or academic achievements.
James R. Halpert, Ph.D.
Dr. James Halpert is Dean of the School of Pharmacy and Professor of Pharmacology and Toxicology at the University of Connecticut. He earned his B.A. in Scandinavian Languages from the University of California at Los Angeles in 1971, his Ph.D. in Biochemistry from Uppsala University, Sweden in 1977, and his M.S. in Toxicology from the Karolinska Institute, Sweden in 1978. After post-doctoral training with Dr. Robert A. Neal in the Center for Environmental Toxicology at Vanderbilt University, Dr. Halpert held a research assistant professor position at the Karolinska Institute from 1981-1983. Then he joined the faculty of the Department of Pharmacology and Toxicology at the University of Arizona. In 1991, Dr. Halpert was promoted to Professor and appointed as Assistant Director of the Center for Toxicology. In that capacity, he was the driving force behind the establishment of a center funded by the National Institute of Environmental Health Sciences (NIEHS) and was named Deputy Director. In 1998, he assumed the position of Professor and Chair of the Department of Pharmacology and Toxicology at the University of Texas Medical Branch in Galveston. There Dr. Halpert recruited 10 tenure-track faculty members, developed a program in Chemical Biology with support from the Robert A. Welch Foundation, and oversaw a five-fold increase in research funding in the department. From 1998-2004 he was a Foreign Adjunct Professor at the Karolinska Institute. Dr. Halpert also served from 2003-2008 as Director of the NIEHS Center in Galveston, Interim Director of the Sealy Center for Environmental Health and Medicine, and held the Mary Gibbs Jones Distinguished Chair in Environmental Toxicology. These centers encompassed basic science, clinical research, and community outreach, and a major focus was to develop translational research. In 2008, Dr. Halpert joined UCSD’s Skaggs School of Pharmacy and Pharmaceutical Sciences as Professor and Associate Dean for Scientific Affairs and was pivotal in the recruitment of 10 tenure-track faculty members and emergence of this new pharmacy school as one of the top 10 in NIH funding. In June 2014, he assumed his position at the University of Connecticut, where he has already been instrumental in obtaining of a joint award with Yale for a $10M Program in Innovative Therapeutics for Connecticut’s Health supported by the state.
- 2016 Award in Excellence in Pharmacology/Toxicology
- 1984 Research Starter Grant in Pharmacology/Toxicology
- 1984 Faculty Development Award
David J. Greenblatt, M.D.
Dr. Greenblatt has been on the Faculty of Tufts University School of Medicine and the Staff of Tufts Medical Center since 1979. He holds the Louis Lasagna, M. D., Endowed Professorship in the Department of Integrative Physiology and Pathobiology at Tufts University School of Medicine, and is Director of the institution’s Clinical Pharmacology Group. Dr. Greenblatt is a senior faculty member in the Graduate Program in Pharmacology & Experimental Therapeutics at the Sackler School of Graduate Biomedical Sciences at Tufts University. He also holds appointments as Professor of Psychiatry, Medicine, and Anesthesia, Tufts University School of Medicine. He has previously served as Chair of the Department of Pharmacology and Experimental Therapeutics at Tufts University School of Medicine, Program Director and Associate Program Director of the institution’s Clinical/Translational Research Center (formerly the General Clinical Research Center), and Chair of the Institutional Review Board. He is Editor-in-Chief of Clinical Pharmacology in Drug Development, operated by the American College of Clinical Pharmacology. He also is Co-Editor-in-Chief, with Dr. Richard I. Shader, of the Journal of Clinical Psychopharmacology.
- 2016 Award in Excellence in Clinical Pharmacology
- 1980 Unit Award in Clinical Pharmacology
Christopher M. Sinko, Ph.D.
Christopher Sinko, Ph.D., is Senior Vice President of Pharmaceutical Development at Bristol–Myers Squibb (BMS). Dr. Sinko earned his B.S. in chemical engineering with a concentration in materials engineering from Rutgers University. He received his M.S. and Ph.D. in pharmaceutics at the University of Michigan College of Pharmacy. In 1987, Dr. Sinko was awarded the PhRMA Foundation Pre Doctoral Fellowship in Pharmaceutics, which he said helped validate the importance of his research. He joined the Upjohn Company in 1989 to develop formulations for monoclonal antibodies targeting HIV, and was recruited to Pfizer Central Research to establish a materials science laboratory for developing solid dosage forms. From 1991 to 2008, Dr. Sinko held various leadership roles at Pfizer, including Executive Director of Global Materials Science, Senior Director of Analytical R&D, and Director of Pharmaceutical R&D. In 2008, he accepted a position to lead Drug Product Science and Technology at BMS. His current role spans chemical, analytical, and formulation development for small molecules and biologics, as well as clinical supplies manufacturing and distribution.David J. Greenblatt, M.D.James R. Halpert, Ph.D.David L. Eaton, Ph.D.Mark J. Ratain, M.D.Christopher M. Sinko, Ph.D.Teruna J. Siahaan, Ph.D.Nancy R. Zahniser, Ph.D.Terrence F. Blaschke, M.D.Raj Suryanarayanan (Sury), Ph.D.Juan J. L. Lertora, M.D., Ph.D.William B. (Bill) Campbell, Ph.D.Andre Terzic, M.D., Ph.D.Margarita L. Dubocovich, Ph.D.Scott A. Waldman, M.D., Ph.D., F.C.P.Bryan L. Roth, M.D., Ph.D.Raymond L. Woosley, M.D., Ph.D.Roger A. Nicoll, M.D.
- 2015 Award in Excellence in Pharmaceutics
- 1987 Pre Doctoral Fellowship in Pharmaceutics